Compare SVM & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVM | INSP |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2005 | 2018 |
| Metric | SVM | INSP |
|---|---|---|
| Price | $10.55 | $70.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 17 |
| Target Price | $15.25 | ★ $62.80 |
| AVG Volume (30 Days) | ★ 1.6M | 870.3K |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | ★ 0.24% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $6.33 | N/A |
| Revenue Next Year | $74.57 | $3.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $5.95 | $38.91 |
| 52 Week High | $15.77 | $147.03 |
| Indicator | SVM | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 37.75 | 55.82 |
| Support Level | $9.66 | $68.13 |
| Resistance Level | $13.31 | $78.80 |
| Average True Range (ATR) | 0.42 | 3.64 |
| MACD | -0.17 | -0.68 |
| Stochastic Oscillator | 9.02 | 25.68 |
Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.